Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastases-Reference-Cited by-同舟云学术

Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastases

Published:2023-03-13 Issue: Volume: Page:
ISSN:1531-0043
Container-title:Clinics in Colon and Rectal Surgery
language:en
Short-container-title:Clin Colon Rectal Surg

Author:

Shah Rupen¹,Gangi Alexandra²

Affiliation:

1. Division of Surgical Oncology, Henry Ford Cancer Institute/Henry Ford Health, Detroit, Michigan

2. Division of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, California

Abstract

AbstractPeritoneal metastases from colon cancer are a particularly challenging disease process given the limited response to systemic chemotherapy. In patients with isolated peritoneal metastases, cytoreductive surgery with hyperthermic intraperitoneal chemotherapy offers a potential treatment option to these patients with limited peritoneal metastases as long as a complete cytoreduction is achieved. Decision about a patient's candidacy for this treatment modality should be undertaken by a multidisciplinary group at expert centers.

Publisher

Georg Thieme Verlag KG

Subject

Gastroenterology,Surgery

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-1758759.pdf

Reference57 articles.

1. Cancer statistics, 2022;R L Siegel;CA Cancer J Clin,2022

2. Actual survival after resection of primary colorectal cancer: results from a prospective multicenter study;I van den Berg;World J Surg Oncol,2021

3. Colorectal cancer: prevention and management of metastatic disease;P H Sugarbaker;BioMed Res Int,2014

4. Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes;D Massalou;Am J Surg,2017

5. The natural history of free cancer cells in the peritoneal cavity;Y Yonemura;Recent Results Cancer Res,2007